← All companies

BCAX

Bicara Therapeutics Inc.

BCAX Nasdaq Pharmaceutical Preparations EDGAR ↗

$25.74

-1.36 -5.02%

Key statistics

from XBRL data in SEC filings

Market cap

$1.69B

Revenue (TTM)

—

Net income (TTM)

-$157M

EPS (TTM)

$-2.77

P/E ratio

—

Dividend yield

—

Free cash flow

-$107M

Cash

$323M

Total assets

$554M

Gross margin

—

52-week range

$9.57 – $30.99

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Regulation FD disclosure Jul 28, 2026 8-K Shareholder vote results Jun 10, 2026 8-K Other events May 21, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release) Mar 30, 2026 8-K Entered a material agreement; Results of operations (earnings release) Feb 26, 2026 8-K Other events Feb 19, 2026 8-K Other events Jan 12, 2026 8-K Regulation FD disclosure; Other events Dec 8, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Shareholder vote results Jun 12, 2025 8-K Entered a material agreement Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 12, 2024 8-K Amended charter or bylaws Sep 16, 2024

Other filings

4 FORM 4 Jul 29, 2026 4 FORM 4 Jul 29, 2026 3 FORM 3 Jul 29, 2026 3 FORM 3 Jul 29, 2026 SCHEDULE 13G Jul 27, 2026 4 FORM 4 Jul 14, 2026 4 FORM 4 Jul 10, 2026 4 FORM 4 Jul 10, 2026 144 Jul 10, 2026 144 Jul 8, 2026 144 Jul 8, 2026 144 Jul 8, 2026 144 Jul 7, 2026 144 Jun 25, 2026 4 Jun 10, 2026